A Head-to-Head Comparison A pivotal clinical trial that directly compared these two medications shifted the landscape
Others are interested in its potential effects on exercise recovery, sleep quality and body composition, although these outcomes have not been confirmed in robust human studies
Zilleruelo, G., Novak, M., Hsia, S
Mounjaro (tirzepatide), on the other hand, activates GLP-1 and GIP , which generally produces stronger weight loss outcomes than GLP-1 alone
The APP was designed as a reporting and scoring pathway available only to MIPS eligible clinicians identified on the Participation List or Affiliated Practitioner List of an APM Entity participating in a MIPS APM as defined in 414.1305 (MIPS APM participants) ( 414.1367(a))